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In mammals, the early phase of B cell develop-
ment occurs in the bone marrow (Hardy and 
Hayakawa, 2001). Hematopoietic progenitors 
located in the marrow differentiate into pro–B 
cells, which initiate rearrangement of Ig heavy 
chain genes. Successful rearrangement leads to 
the production of Ig  heavy chain, its assem-
bly into the pre-BCR, and signaling from this 
receptor, resulting in proliferative expansion and 
differentiation into pre–B cells. Pre–B cells re-
arrange Ig light chain genes, and if successful, 
light chains associate with the  heavy chain, 
resulting  in  expression  of  BCR  in  the  form   
of IgM on the surface of an immature B cell. 
Signaling from the BCR in immature B cells   
allows the cells to move into the late phase of   
B cell development, B cell positive selection, 
which occurs in part in the spleen.
Immature B cells migrate from the bone mar-
row to the spleen, where they are now termed 
transitional B cells. Arriving from the blood, 
transitional  B  cells  first  enter  the  marginal   
sinus and the red pulp of the spleen, and then 
migrate across the marginal sinus lining cells 
into the white pulp (Mebius and Kraal, 2005). 
Here they acquire expression of IgD, an alter-
native form of the BCR, and complete their 
maturation into mature recirculating follicular 
(MRF) B cells or marginal zone (MZ) B cells. 
Although MZ B cells reside mainly in the   
MZ of the spleen, MRF B cells are found pri-
marily in follicles of both the spleen and other 
lymphoid organs, such as lymph nodes and 
Peyer’s patches, and recirculate between them, 
exiting lymphoid organs through the lymphat-
ics  and  returning  via  the  blood  vasculature. 
Thus, cell migration is intimately involved in 
both B cell development and in the function 
of mature B cells.
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Rac1 and Rac2 GTPases transduce signals from multiple receptors leading to cell migration, 
adhesion, proliferation, and survival. In the absence of Rac1 and Rac2, B cell development 
is arrested at an IgD transitional B cell stage that we term transitional type 0 (T0). We 
show that T0 cells cannot enter the white pulp of the spleen until they mature into the  
T1 and T2 stages, and that this entry into the white pulp requires integrin and chemokine 
receptor signaling and is required for cell survival. In the absence of Rac1 and Rac2, transi-
tional B cells are unable to migrate in response to chemokines and cannot enter the splenic 
white pulp. We propose that loss of Rac1 and Rac2 causes arrest at the T0 stage at least in 
part because transitional B cells need to migrate into the white pulp to receive survival 
signals. Finally, we show that in the absence of Syk, a kinase that transduces B cell antigen 
receptor signals required for positive selection, development is arrested at the same T0 
stage, with transitional B cells excluded from the white pulp. Thus, these studies identify a 
novel developmental checkpoint that coincides with B cell positive selection.
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Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six  months  after  the  publication  date  (see  http://www.rupress.org/terms).   
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Noncommercial–Share  Alike  3.0  Unported  license,  as  described  at  http://
creativecommons.org/licenses/by-nc-sa/3.0/).
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(Walmsley et al., 2003). Specifically, the number of T1 B cells 
was reduced by 80%, and all subsequent stages of develop-
ment (T2 and mature subsets) were almost completely absent. 
The T1 subset of B cells contains the most recently arrived im-
mature B cells, which have migrated from the bone mar-
row, through the blood to the spleen, where they complete 
their maturation. In view of the documented role of Rac 
GTPases in cell mobility and adhesion, we considered whether 
the developmental defect in B cells deficient in Rac1 and 
Rac2 may be caused by inefficient migration. To study these 
processes, we used mice bearing a conditional loxP-flanked 
allele of Rac1 (Rac1flox/flox) crossed to CD19Cre/+ mice to give B 
lineage–specific deletion of Rac1 (Rac1B), mice constitutively 
deficient in Rac2 (Rac2/), and mice deficient in both   
GTPases (Rac1BRac2/; Walmsley et al., 2003).
Previously, we analyzed transitional splenic B cell subsets 
according to expression of CD21, CD23, and CD24 using the 
system of Loder et al. (1999). We now used an alternative system 
devised by Allman et al. (2001) in which transitional subsets are 
identified based on expression of CD93, IgM, and CD23. In this 
separation, we noted that the T1 subset (CD93+IgMhighCD23) 
was heterogeneous with respect to IgD expression, containing 
both IgD and IgD+ cells (Fig. 1 A). Because immature B cells 
first express IgM and subsequently IgD, it was likely that the 
IgD cells developmentally precede the IgD+ cells, and hence, 
for simplicity, we refer to the former as T0 cells and to the latter 
as T1 IgD+ cells (Fig. 1 A). This assumption about the develop-
mental order of the T0 and T1 IgD+ subsets is supported by 
evidence presented at the end of this section. Enumeration 
of these subsets showed that deficiency for both Rac1 and 
Rac2 did not affect the numbers of T0 cells but led to a large   
decrease in both T1 IgD+ and T2 transitional subsets (Fig. 1 B). 
As previously seen using the Loder et al. (1999) staining pro-
tocol (Walmsley et al., 2003), the number of MRF and MZ B 
cells was also greatly reduced (Fig. 1 B).
We also measured the numbers of both immature and 
mature B cells in the blood. In the absence of both Rac1 and 
Rac2 there was a >10-fold increase in the number of imma-
ture B cells in the blood (Fig. 1, C and D). More specifically, 
this increase was in the T0-like immature B cells (Fig. S1 A). 
These cells are presumably in transit between the bone mar-
row and spleen. At the same time, there was a decrease in the 
number of mature B cells in the blood (Fig. 1, C and D), in 
accordance with large decreases seen in the lymph nodes and 
spleen. Previous studies have shown that transitional B cell 
maturation can occur in locations other than the spleen, such 
as the bone marrow (Cariappa et al., 2007; Lindsley et al., 
2007). Examination of bone marrow in mice deficient in 
both Rac1 and Rac2 showed that although the number of 
pro–B, pre–B, and T0-like immature B cells was not altered, 
there was a significant decrease in T1 IgD+-like and T2-like 
immature B cells (Fig. S1 B). Collectively, these results show 
that in the absence of Rac GTPases, T0-like immature B 
cells accumulate in the blood, and B cell development is 
strongly blocked between T0 and T1 IgD+ B cells in both 
the spleen and bone marrow.
The recirculation of MRF B cells between the splenic and 
lymph node follicles, and the lymphatic and blood systems, has 
been shown to require coordinated signaling through chemokine, 
integrin, and sphingosine-1-phosphate receptors (Cyster, 2005). 
In contrast, relatively little is known about the movement of   
immature/transitional B cells from bone marrow to the spleen.
In mice engineered to lack expression of both Rac1 and 
Rac2, B cell development is blocked at a transitional B cell stage 
in the spleen (Walmsley et al., 2003). Rac1 and Rac2 are mem-
bers of the Rho family of GTPases, proteins that transduce   
signals from antigen receptors such as the BCR, as well as che-
mokine and integrin receptors (Walmsley et al., 2003; Jaffe and 
Hall, 2005; Cancelas et al., 2006). Signals from Rac GTPases in 
turn activate a diverse set of cellular responses, including regula-
tion of the actin cytoskeleton, proliferation, survival, migration, 
and adhesion. In view of the requirement for signals from the 
BCR and the BAFF receptor BAFF-R during this late phase of 
B cell development, the block in B cell development at a transi-
tional B cell stage in the absence of Rac1 and Rac2 could be 
caused by defects in signaling from either receptor. Indeed in an 
earlier study, we showed that immature B cells deficient in Rac1 
and Rac2 are defective in BAFF-induced survival (Walmsley   
et al., 2003). However, it is also possible that Rac1 and Rac2 
transduce chemokine or integrin receptor signals in immature or 
transitional B cells that control their exit from the bone marrow, 
and migration through blood to the red pulp of the spleen and 
then into the white pulp, finally arriving in the follicles.
Thus, in this study we addressed the question of whether   
the developmental block seen in the absence of Rac1 and Rac2 
was caused at least in part by roles for the GTPases in migration 
or adhesion of transitional B cells. We show that deficiency   
of these GTPases leads to developmental arrest at an IgD tran-
sitional B cell stage that we term transitional type 0 (T0), consist-
ing of the most immature splenic transitional B cell immigrants. 
We show that T0 transitional B cells can freely migrate into the 
red pulp of the spleen but are unable to enter the white pulp and 
the follicles until they mature into the T1 and T2 stages.   
Furthermore, we demonstrate that entry of T1 and T2 transi-
tional B cells into the white pulp requires the integrins LFA-1 
and VLA-4, as well as signaling from pertussis toxin–sensitive 
receptors, most likely chemokine receptors, and we show that 
migration into the white pulp is required for cell survival. More-
over, we show that although transitional B cells can enter the red 
pulp in the absence of Rac1 and Rac2, they are unable to enter 
the white pulp because of defective chemokine receptor signal-
ing, leading to cell death and hence a developmental block.   
This novel Rac-dependent checkpoint in B cell development,   
defined by migration of transitional B cells into the white pulp 
of the spleen, coincides with the positive selection of B cells.
RESULTS
Deficiency of Rac1 and Rac2 leads to identification  
of an IgD transitional subset of B cells
In earlier studies, we showed that in the absence of Rac1 and 
Rac2, B cell development proceeds normally within the   
bone marrow but is blocked in the spleen at an early T1 stage   JEM VOL. 207, April 12, 2010 
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bone marrow and blood, and in splenic T0 or T2 B cell sub-
sets compared with their WT counterparts (Fig. 2). However, 
the pulse-chase study showed that Rac-deficient T1 IgD+ 
splenic B cells turned over more rapidly than WT cells. This 
mild increase in turnover suggests that the reduced size of the 
splenic T1 IgD+ subset in Rac1BRac2/ mice is in part caused 
by more rapid exit of cells from this compartment, perhaps 
because of increased death. In addition, although the normal 
size and turnover of the Rac1BRac2/ T0 subset shows that 
its output is normal, if these cells are the direct precursors of 
T1 IgD+ cells, we estimate that at most 14 ± 2% of them   
mature into the T1 IgD+ subset, in contrast to 52 ± 4% of WT 
T0 cells. Thus, most Rac1BRac2/ T0 cells are not becoming 
T1 IgD+ B cells but have other developmental fates. These 
could include migration to another location or cell death.
Comparison of rates of labeling and turnover of different 
B lineage subsets shows that immature (T0-like) B cells in the 
bone marrow label more rapidly than those in the blood and 
spleen. Splenic T0 and T0-like immature B cells in the blood 
label with identical kinetics, suggesting that they form one 
recirculating compartment. Furthermore, splenic T0 B cells 
acquire BrdU more rapidly than do T1 IgD+ B cells, which 
in turn are more rapid than T2 B cells (Fig. 2). Collectively, 
these results are consistent with a developmental progression 
from immature bone marrow B cells to blood/spleen T0 cells 
to T1 IgD+ cells to T2 cells.
Immature Rac-deficient B cells accumulate in the blood 
because of defective CXCR4-mediated migration to the 
bone marrow
To investigate further why immature T0-like Rac1BRac2/ 
B cells accumulate in the blood, we adoptively transferred 
splenic T0 cells from Rac-deficient mice into WT recipients. 
The transferred cells were mixed with WT T0 cells to act as a 
reference population, and the location of the transferred cells 
was assessed 4 h after transfer. These studies showed that   
although T0 cells deficient in either Rac1 or Rac2 alone   
localized normally, there was a significant accumulation of   
Rac1BRac2/ T0 cells in the blood and a decrease of these 
cells in the bone marrow (Fig. 3 A). In contrast, the number 
of Rac1BRac2/ T0 cells in the spleen was unaltered. These 
results suggest that the accumulation of immature B cells in 
the blood of Rac1BRac2/ mice may be caused by a reduced 
ability of splenic T0 cells to traffic to the bone marrow.
It is known that the chemokine CXCL12, acting through 
the CXCR4 receptor, is critical for the retention of develop-
ing B lineage cells in the bone marrow and for the homing 
of mature B cells to the marrow (Ma et al., 1999; Nie et al., 
2004). Furthermore, Rac GTPases have been implicated in 
CXCR4 signaling (Cancelas et al., 2006). Thus, we hypoth-
esized that the accumulation of T0 Rac-deficient B cells in 
the blood and their decreased migration back into the bone 
marrow may be caused by defective CXCR4 function. In 
support of this, transfer of WT T0 B cells in the presence of 
an inhibitor of CXCR4 replicated the phenotype of Rac-
deficient T0 cells, resulting in an accumulation of cells in the 
To gain further understanding of why Rac1 and Rac2   
are required for the maturation of T0 B cells into T1 IgD+  
B cells, we measured the turnover of these subsets by adminis-
tration of BrdU in the drinking water of the mice either con-
tinuously or using a pulse-chase protocol. BrdU is incorporated 
by cycling pre–B cells in the bone marrow, and because all 
subsequent subsets are noncycling, the rate at which subsets 
become BrdU+ reflects their intrinsic rate of turnover (Fulcher 
and Basten, 1997). These studies showed no significant differ-
ence in the turnover of Rac1BRac2/ immature B cells in the 
Figure 1.  Immature B cells are blocked in splenic development and 
accumulate in the blood in the absence of Rac1 and Rac2. (A) Con-
tour plots of splenocytes from either WT or Rac1BRac2/ mice showing 
separation of B220+ cells into immature (CD93+) and mature (CD93)  
B cells. The immature cells were then further gated on IgM+ cells and sepa-
rated according to the expression of IgD and CD23 into T0 (IgDCD23), 
T1 IgD+ (IgD+CD23), and T2 (IgD+CD23+) subsets. Mature (CD93) cells 
were separated according to expression of IgM and CD23 into MRF  
(IgM+/CD23+) and MZ (IgM+CD23) subsets (not depicted). Numbers show 
the percentage of cells falling into gates or quadrants. (B) Mean (±SEM) 
numbers of T0, T1 IgD+, T2, MRF, and MZ splenic B cells in mice of the 
indicated genotypes (n = 6). (C) Contour plots showing expression of IgM 
and IgD on B220+ blood lymphocytes. Gates indicate immature (IgM+IgD) 
and MRF (IgD+) B cells. Numbers show the percentage of cells falling into 
gates. (D) Mean (±SEM) numbers of immature and MRF B cells in the 
blood of mice of the indicated genotypes (n = 5). *, P < 0.05; **, P < 0.01.840 Migration in transitional B cell development | Henderson et al.
less efficiently. Histological analysis demonstrated that at 4 h 
both WT and Rac-deficient transferred T0 cells were located 
largely in the red pulp of the spleen. Strikingly, however, by 
24 h many of the transferred WT cells had entered the white 
pulp, whereas the Rac1BRac2/ cells were largely excluded 
(Fig. 4 C). Quantitation of these results showed that although   
Rac1-deficient transitional B cells entered the white pulp nor-
mally, Rac2-deficient cells were partially defective and cells 
missing both GTPases were almost completely arrested in the 
red pulp (Fig. 4 D). The inability of T0 cells to enter the white 
pulp 4 h after transfer is most likely caused by their immatu-
rity, as MRF B cells readily home into the white pulp even at 
this early time point (Fig. 4, C and D). Thus, we conclude 
that there appears to be no barrier to entry of WT T0 B cells 
from the blood to the splenic red pulp; however, their subse-
quent entry into the white pulp requires more time, most 
likely because they need to mature into T1 IgD+ and T2 B 
cells. In contrast, in the absence of Rac1 and Rac2, transi-
tional B cells are unable to gain entry into the white pulp 
despite at least some maturation into T1 IgD+ and T2 cells.
If some of the transferred Rac1BRac2/ T0 cells can ma-
ture into T1 IgD+ and T2 cells, why do these cells not accu-
mulate in the intact mice? One possibility is that the cells die 
at this developmental stage. We examined this by measuring 
cell recovery 24 h after transferring WT or Rac-deficient T0 
B cells into WT hosts. This clearly showed that although   
recovery was normal 4 h after transfer (Fig. 3 A), many fewer 
Rac1BRac2/  transitional  cells  were  recovered  compared 
with their WT counterparts at 24 h (Fig. 4 E). Strikingly, this 
reduction was caused by large decreases in the number of T1 
blood, a decrease in the bone marrow, and no effect on   
homing to the spleen (Fig. 3, compare B with A). Further-
more, we found that in the absence of both Rac1 and Rac2, 
immature bone marrow B cells and splenic T0 B cells are un-
able to chemotax toward CXCL12, unlike WT cells (Fig. 3 C).   
This was true even when the assay was performed in the 
presence of VCAM-1, the ligand for integrin VLA-4 (41), 
which is activated by CXCL12 and also plays a role in the 
retention of developing B cells in the bone marrow (Koni   
et al., 2001). We conclude that the accumulation of Rac1- 
and Rac2-deficient immature B cells in the blood may   
result  from  defective  CXCR4-mediated  migration  of  the 
cells to the bone marrow. We note that in contrast to CXCR4- 
deficient mice (Nie et al., 2004), we do not see premature 
release of pro–B and pre–B cells from the bone marrow of 
Rac1BRac2/ mice. This is most probably because deletion 
of Rac1 in these early subsets is incomplete, only becoming 
efficient in immature B cells (Walmsley et al., 2003).
Rac-deficient T0 B cells are unable to enter the white pulp 
of the spleen
The normal homing of Rac-deficient T0 B cells to the spleen 
(Fig. 3 A) did not explain why development of the cells is   
arrested. Thus, we examined the maturation and localization 
of the transferred cells 4 and 24 h after transfer. Flow cytom-
etry showed that at 4 h the transferred cells were still largely 
T0 in phenotype, whereas by 24 h many of the WT cells had 
acquired expression of IgD and/or CD23 and thus resembled 
T1 IgD+ and T2 B cells (Fig. 4, A and B). The Rac1BRac2/ 
T0 B cells also matured into T1 IgD+ and T2 B cells, albeit 
Figure 2.  Analysis of population turnover by BrdU incorporation. (A and B) Turnover of immature T0-like B cells in the bone marrow and blood 
(CD93+IgM+IgDCD23) and of splenic T0, T1 IgD+, T2, and MRF B cells from mice of the indicated genotypes monitored by (A) continuous (n = 5–6) or 
(B) pulse-chase analysis of BrdU incorporation (n = 4–5) as a function of time after start of BrdU treatment. BrdU was administered to the mice starting 
at time 0. For pulse-chase analysis, BrdU was administered for the first 16 h only. Means ± SEM are shown. *, P < 0.05.JEM VOL. 207, April 12, 2010 
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and anti–VLA-4 blocking antibodies, or after treatment with 
pertussis toxin. Although the antiintegrin antibodies partially 
reduced the movement of transitional B cells into the white 
pulp, pertussis toxin almost completely blocked the move-
ment, to a level similar to that seen with Rac1BRac2/ tran-
sitional B cells (Fig. 5 A). Thus, we conclude that, similar to 
mature B cells, the entry of transitional B cells into the white 
pulp requires the integrins LFA-1 and VLA-4 as well as pertus-
sis toxin–sensitive receptors.
In addition, pertussis toxin treatment partially blocked 
maturation of the T0 cells into T1 IgD+ and T2 cells and   
reduced cell recovery at 24 h (Fig. 5, B and C). Notably, 
pertussis toxin treatment caused a drop in recovery of T1 
IgD+ and T2 cells (Fig. 5 C). We note the similarity of this 
result to that seen in cells deficient in Rac GTPases (compare 
with Fig. 4 E). Collectively, these results suggest that both 
Rac GTPases and pertussis toxin–sensitive receptors are re-
quired for the entry of transitional B cells into the white 
pulp and for the survival of T1 IgD+ and T2 B cells.
Rac1 and Rac2 are required for chemokine responsiveness 
of transitional B cells
In view of the pertussis toxin sensitivity of transitional B cell 
migration into the splenic white pulp, we investigated the 
ability of transitional B cells to respond to CCL21, CXCL12, 
and CXCL13. In Transwell migration assays, we found that 
as cells matured from T0 to T1 IgD+ to T2, they became 
more responsive to chemokines, especially to CCL21 and 
CXCL13, which are known to direct migration of lympho-
cytes into the T and B cell areas of the white pulp, respec-
tively  (Fig.  6  A;  Ohl  et  al.,  2003).  This  maturation  was 
accompanied by an increase in surface levels of LFA-1 (both 
L  and  2  subunits)  and  of  CXCR5,  the  receptor  for 
CXCL13, whereas the levels of VLA-4 (both 4 and 1   
subunits) and of CXCR4, the receptor for CXCL12, re-
mained unchanged (Fig. 6 B). The migration of transitional 
B cells was enhanced in the presence of ICAM-1, a ligand for 
LFA-1, or in the presence of MadCAM-1 and VCAM-1,   
ligands  for  VLA-4  (Fig.  6  C).  In  all  cases,  however,  the   
responsiveness of the cells again increased as they matured 
from T0 to T1 IgD+ to T2. These results are in agreement 
with our observation that transitional B cells need to mature 
from the T0 stage to the T1 IgD+ or T2 stages before they 
can enter the white pulp, and that this migration is dependent 
on both integrins and pertussis toxin–sensitive receptors. We 
note that MadCAM-1 is expressed in the marginal sinus   
lining cells and that ICAM-1 and VCAM-1 are expressed in 
the white pulp, and thus, these integrin ligands are located in 
the right place to mediate entry of transitional B cells into the 
white pulp or their subsequent retention (Lo et al., 2003).
Next, we examined the role of Rac1 and Rac2 in the 
chemokine responsiveness of transitional B cells. Using the 
Transwell assay system, we found that in the absence of both 
GTPases, T0, T1 IgD+, and T2 B cells were almost completely 
unresponsive to CCL21, CXCL12, and CXCL13 (Fig. 6 D). 
This  was  not  caused  by  defective  receptor  expression,   
IgD+ and T2 cells, whereas the number of T0 cells was unaf-
fected. These results imply that Rac1BRac2/ T0 cells are 
able to mature into T1 IgD+ and T2 cells, but these latter 
subsets then fail to survive, thus leading to the large reduction 
in T1 IgD+ and T2 cells seen in the mutant mice.
Entry of transitional B cells into the white pulp  
requires integrins and signaling from pertussis  
toxin–sensitive receptors
Entry of mature B cells into the white pulp of the spleen has 
been shown to require the integrins LFA-1 and VLA-4, as 
well as the function of pertussis toxin–sensitive G protein–
coupled receptors (GPCRs), most likely the CXCR5 and 
CCR7 chemokine receptors (Cyster and Goodnow, 1995; 
Lo et al., 2003; Ohl et al., 2003). To ascertain if the same is 
true for the migration of transitional B cells into the white pulp, 
we transferred WT T0 B cells in the presence of anti–LFA-1   
Figure 3.  Accumulation of Rac-deficient immature B cells in the 
blood may be caused by defective CXCR4 signaling. (A) Splenic T0  
B cells from mice of the indicated genotypes (IgMbLy5.2+) mixed with 
splenic T0 B cells from 129S8 (IgMaLy5.2+) mice were injected into  
B6.SJL (IgMbLy5.1+) mice. Graph shows the mean (±SEM) IgMbLy5.2+ to 
IgMaLy5.2+ ratio of B cells in the blood, spleen, and bone marrow 4 h 
after transfer, normalized to the input ratio (n = 5–17). (B) Mean (±SEM)  
number of IgMb+ cells recovered from the blood, spleen, and bone mar-
row of B6.SJL mice into which WT splenic T0 B cells had been transferred 
4 h earlier in the absence or presence of the CXCR4 inhibitor AMD3100 
(n = 4). (C) Mean (±SEM) migration of immature bone marrow or splenic 
T0 cells from mice of the indicated genotypes in a Transwell assay in 
response to CXCL12. Wells were coated or not () with VCAM-1 (n = 6). 
*, P < 0.05; **, P < 0.01. BM, bone marrow.842 Migration in transitional B cell development | Henderson et al.
of defective chemokine receptor function. Furthermore,   
this failure to enter the white pulp may account in part   
for the defective survival of Rac-deficient transitional B   
cells. This conclusion implies that the reduced survival of 
Rac1BRac2/ T1 IgD+ and T2 B cells in the adoptive transfer 
as the surface levels of both CXCR5 and CXCR4 were un-
changed in the mutant cells (unpublished data). This result,   
together with the requirement for a pertussis toxin–sensitive re-
ceptor for entry into the white pulp, suggests that Rac1BRac2/ 
transitional B cells are unable to enter the white pulp because 
Figure 4.  Transitional B cells deficient in both Rac1 and Rac2 fail to enter the white pulp of the spleen. (A and B) Contour plots show IgD 
and CD23 expression on B220+IgMb+ cells from 129S8 (IgMa) mice into which splenic T0 B cells from WT or Rac1BRac2/ (IgMb) mice had been trans-
ferred (A) 4 h or (B) 24 h earlier. The input cells before transfer are shown for comparison. Numbers indicate percentages of cells falling into quad-
rants. (C) Images showing immunofluorescence staining of sections from spleens of mice into which WT or Rac1BRac2/ (IgMb) T0 B cells had been 
transferred 4 or 24 h earlier. Staining for IgMb (green) identifies transferred T0 B cells, and MadCAM-1 (red) defines the edges of the white pulp. 
(right) Transferred WT MRF B cells for comparison. Bar, 150 µm. (D) Mean (±SEM) ratio of transferred IgMb+ T0 or MRF B cells ending up in white rela-
tive to red splenic pulp at 4 or 24 h after transfer, quantitated using sections such as those shown in C (n = 4–6). (E) Splenic T0 B cells from mice of 
the indicated genotypes (IgMbLy5.2+) were injected into 129S8 (IgMaLy5.2+) mice. Graph shows the mean (±SEM) percent recovery of transitional  
B cells in the spleen 24 h after transfer of T0 cells of the indicated genotype. Recovery of total transitional cells is shown, as well as subdivision of  
these into T0, T1 IgD+, and T2 cells (n = 5–8). *, P < 0.05; **, P < 0.01.JEM VOL. 207, April 12, 2010 
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consequence of positive selection for cells that have success-
fully rearranged light chain genes, resulting in expression of 
cell-surface IgM. The identification of Rac GTPase-dependent 
entry of transitional B cells into the splenic white pulp sug-
gested that this process might represent a checkpoint dur-
ing B cell positive selection. To evaluate this possibility, we   
examined development of B lineage cells in the absence of 
Syk, a tyrosine kinase critical for signaling from the BCR 
(Turner et al., 2000). As reported previously (Cheng et al., 
1995; Turner et al., 1995, 1997), in the absence of Syk we 
found reduced numbers of pre–B and immature B cells in 
the bone marrow and no splenic mature B cells at all, re-
flecting a partial block at the pre-BCR checkpoint and a 
complete block at the BCR checkpoint, B cell positive se-
lection (Fig. 7 B). However, we were able to find a small 
number of transitional B cells in the spleen, almost all of 
which were T0 cells, with only 18 ± 3% falling into T1 
IgD+ or T2 subsets (Fig. 7, A and B). Furthermore, the large 
majority of these Syk-deficient transitional B cells were   
located in the red pulp, with only 11 ± 5% in the white pulp 
(Fig. 7 C). These studies show that like the Rac GTPases, 
the Syk kinase is required for transitional B cells to enter the 
white pulp, and we propose that this process is a critical   
feature of BCR-driven positive selection.
Ectopic expression of Bcl-xL rescues the developmental 
defect in Rac-deficient transitional B cells
The similarity in the developmental arrest and in the survival 
and migratory defects between Rac1BRac2/ and pertussis 
toxin–treated  transitional  B  cells  leads  us  to  propose  that   
although  Rac-deficient  transitional  T0  B  cells  are  able  to   
differentiate into the T1 IgD+ and T2 stages, they are unable 
to migrate into the splenic white pulp and hence die because 
they cannot receive an essential survival signal that is only 
available in the white pulp. However, an alternative interpre-
tation, based on the similarity of the developmental block in 
Rac1BRac2/ and Syk/ transitional B cells, is that the Rac 
GTPases, like Syk, are required to transduce a BCR signal 
leading to differentiation of the cells into mature B cells. To 
distinguish these possibilities, we used retroviral gene transduc-
tion to ectopically express the prosurvival Bcl-xL protein in 
Rac1BRac2/ transitional B cells. If the requirement for Rac 
GTPases is to transduce chemokine receptor signals, allowing 
transitional B cells to migrate into the white pulp and hence 
receive a survival signal, expression of Bcl-xL should rescue 
cell survival and hence reverse the developmental block with-
out affecting the migratory defect. If, on the other hand, Rac 
proteins transduce BCR positive selection signals required for 
cell maturation, then ectopic expression of Bcl-xL will increase 
cell  survival  but  will  not  rescue  the  developmental  block.   
Exactly this outcome was seen using the related prosurvival 
Bcl2 protein, which was unable to rescue the developmental 
defect in Syk/ transitional B cells (Turner et al., 1997).
Bcl-xL expression was forced by using the MIGR1–Bcl-xL 
retroviral vector to transduce bone marrow cells from WT 
or Rac1BRac2/ mice, which were then used to reconstitute 
studies (Fig. 4 E) would not be further impaired by treat-
ment with pertussis toxin, and this is indeed what we find 
(Fig. 5, D and E).
Entry of transitional B cells into the splenic white pulp 
coincides with B cell positive selection
Migration of immature B cells from the bone marrow to the 
splenic white pulp and other secondary lymphoid organs is a 
Figure 5.  Pertussis toxin blocks entry of T0 splenic B cells into the 
white pulp, as well as their survival. (A) Mean (±SEM) ratio of trans-
ferred IgMb+ T0 B cells ending up in white relative to red splenic pulp at 
24 h after transfers, as described in Fig. 4 (A–C). Transferred T0 cells were 
from WT or Rac1BRac2/ mice. In some transfers of WT T0 B cells, the 
mice were pretreated with anti–LFA-1 and anti-4 blocking antibodies  
(antiintegrin mAb), or the cells were treated with pertussis toxin  
(n = 4–6). (B and D) Contour plots show expression of IgD and CD23 on 
B220+IgMb+ splenocytes from 129S8 (IgMa+) mice into which (B) WT or 
(D) Rac1BRac2/ (T0 B cells (both IgMb+) had been transferred 24 h ear-
lier and had been either pretreated with pertussis toxin or an oligomer of 
the B subunit of pertussis toxin (Oligo B). Oligo B controlled for any ef-
fects of pertussis toxin independent of the ADP-ribosylation activity of 
the A subunit, which inactivates Gi-coupled GPCRs. Staining of input 
cells before transfer is shown for comparison. Numbers indicate percent-
ages of cells falling into quadrants. (C and E) Graphs show the mean 
(±SEM) percent recovery of transitional B cells in the spleens of 129S8 
mice 24 h after transfer of WT (C; n = 4–5) or Rac1BRac2/ (E; n = 6–7) 
T0 B cells pretreated with Oligo B or pertussis toxin. Recovery of total 
transitional cells is shown as well as subdivision of these into T0, T1 IgD+, 
and T2 cells. *, P < 0.05; **, P < 0.01. PTX, pertussis toxin.844 Migration in transitional B cell development | Henderson et al.
tional B cells because they transduce chemokine signals, 
allowing the cells to migrate to the white pulp where they 
receive survival signals.
The Vav exchange factors are not required for entry  
into the white pulp
The Vav family of guanine nucleotide exchange factors 
(GEFs) transduce antigen receptor signals to the activation of 
Rac proteins in both B and T cells (Turner and Billadeau, 
2002; Tybulewicz, 2005). They have also been shown to play 
critical roles in lymphocyte development, most likely because 
they transduce antigen receptor signals controlling lympho-
cyte selection. In the absence of all three family members, 
irradiated Rag1-deficient mice. The MIGR1–Bcl-xL vector 
clearly gave rise to increased Bcl-xL expression in both WT 
and Rac-deficient transitional B cells (Fig. 8 A). Although in-
creased Bcl-xL expression had no effect on the development 
of WT transitional cells, it resulted in a decrease in the per-
centage of Rac-deficient transitional B cells at the T0 stage 
and a comparable increase in the percentage of T1 IgD+ cells 
(Fig. 8, B and C). As expected, Bcl-xL overexpression did 
not rescue the defective chemotaxis of Rac-deficient transi-
tional B cells (Fig. 8 D). This result shows that the develop-
mental block in Rac1BRac2/ mice is caused by the failure 
of transitional B cells to survive, and supports the hypothesis 
that Rac GTPases are essential for the survival of transi-
Figure 6.  Migration in response to lymphoid chemokines is defective in transitional B cells deficient in Rac1 and Rac2. (A) Mean (±SEM) 
migration in a Transwell assay of T0, T1 IgD+, and T2 splenic B cells from a WT mouse in response to CCL21, CXCL12, CXCL13, or no chemokine (n = 6). 
(B) Histograms showing cell-surface levels of 4, L, 1, and 2 integrins, and CXCR4 and CXCR5 on T0, T1 IgD+, and T2 B cell subsets. (C) Graph as 
in A, with migration in response to different chemokines assayed in the presence of the integrin ligands ICAM-1, MadCAM-1, or VCAM-1, or with no 
ligand present (n = 6). (D) Graph as in A, comparing chemokine-induced migration of transitional B cells from WT and Rac1BRac2/ mice (n = 6).  
*, P < 0.05; **, P < 0.01. No Chmk, no chemokine.JEM VOL. 207, April 12, 2010 
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and are able to traffic normally to the splenic white pulp. 
Hence, the defects in chemokine responses and migration to 
the white pulp seen in the absence of Rac proteins must   
reflect pathways using Rac GEFs other than the Vav family.
Rac2 is required for LFA-1–mediated adhesion
Chemokine receptor signaling activates integrin-mediated 
adhesion, a process believed to be critical in migration of 
lymphocytes between the blood and the peripheral lym-
phoid organs. Furthermore, Rac proteins have been impli-
cated in both inside-out signaling leading to the activation 
of integrins and outside-in signaling from integrins resulting 
in firm adhesion (Rose et al., 2007). Thus, the inability of 
Rac-deficient transitional B cells to migrate into the splenic 
white pulp may be caused by defects in signaling from che-
mokine receptors, integrins, or both. To investigate this 
further, we studied integrin-mediated adhesion in Rac-
  deficient B cells. Because we were unable to detect such 
adhesion using transitional cells, we studied the role of Rac 
proteins in chemokine and integrin function using mature 
B cells. In addition, because mature B cells deficient in both 
GTPases do not develop in Rac1BRac2/ mice (Walmsley 
et al., 2003), we were instead limited to B cells missing   
either Rac1 or Rac2 alone.
Transfer experiments showed that although WT and 
Rac1-deficient mature B cells efficiently enter the splenic 
white pulp, the absence of Rac2 causes a marked reduction 
in this migration (Fig. 10 A). To measure integrin-mediated 
adhesion of B cells, we made use of a system in which the 
Vav1, Vav2, and Vav3, B cell development is almost com-
pletely blocked at a transitional B cell stage (Fujikawa et al., 
2003; Vigorito et al., 2005). In view of the apparent similarity 
of this developmental phenotype to that in Rac-deficient   
mice, we considered whether there may be a Vav–Rac signa-
ling pathway controlling B cell development at the point of 
entry into the splenic white pulp. Thus, we compared B cell 
development and the migration of transitional B cells in mice 
missing either the Vav or Rac proteins.
Enumeration of splenic B cell subsets demonstrated that 
in  mice  missing  all  three  Vav  proteins  (Vav  triple  KO 
[VavTKO]), the number of T0 cells was elevated and the 
number of T1 IgD+ cells was unchanged, whereas the num-
bers of T2, MZ, and MRF B cells were reduced (Fig. 9,   
A and B), in agreement with previous reports showing a block 
in development between the T1 and T2 stages (Fujikawa   
et al., 2003; Vigorito et al., 2005). Analysis of chemokine   
responsiveness  showed  that  lack  of  Vav  proteins  partially   
reduces chemotaxis induced by CCL21 and CXCL13 in T0, 
T1 IgD+, and T2 B cells, and has no effect on CXCL12   
responses; however, these reductions are not as large as those 
seen in Rac1BRac2/ B lineage cells (Fig. 9 C). In agreement 
with this, migration of transitional B cells into the white pulp 
was not affected by the absence of Vav proteins (Fig. 9 D). 
Collectively, these results show that the absence of Vav pro-
teins results in a very different B cell phenotype compared 
with  Rac-deficient  mice.  The  developmental  block  in 
VavTKO mice is at a later stage than that in Rac1BRac2/ 
mice, and the B cells respond reasonably well to chemokines 
Figure 7.  Loss of Syk causes developmental arrest at the T0 transitional B cell stage. (A) Contour plots show IgD and CD23 expression on 
B220+CD93+IgMhi splenocytes from irradiated B6.SJL-Rag2/ mice reconstituted 8 wk earlier with Syk/ or WT fetal liver. Numbers indicate percentages 
of cells falling into quadrants. (B) Mean (±SEM) numbers of pro–B (B220+IgMIgDCD2), pre–B (B220+IgMIgDCD2+), and immature T0-like (Imm; 
B220+CD93+IgM+IgDCD23) cells in the bone marrow and splenic subsets (defined as in Fig. 1 B) of radiation chimeras described in A (n = 6). (C) Images 
showing immunofluorescence staining of sections from spleens of irradiated 129S8 (IgMa) mice reconstituted 8 wk earlier with Syk/ or WT fetal liver. 
Staining for IgMb (green) identifies donor B cells, and MadCAM-1 (red) defines the edges of the white pulp. Bar, 150 µm. **, P < 0.01.846 Migration in transitional B cell development | Henderson et al.
inside-out  signals  from  chemokine  receptors  leading  to 
LFA-1 activation. In contrast, no role for Rac1 could be 
seen in these processes.
We previously reported that Rac2 was also required for 
BCR-induced adhesion to ICAM-1, and suggested that this 
might be caused by a role for Rac2 in the activation of 
Rap1, a GTPase implicated as a regulator of LFA-1, because 
BCR-induced  Rap1  activation  was  partially  reduced  in 
Rac2/ B cells (Arana et al., 2008). To investigate whether 
the same may be true for chemokine receptor signaling, we 
examined Rap1 activation in response to CXCL13. In con-
trast to our earlier studies with BCR stimulation, we found 
that both Rac1- and Rac2-deficient B cells activated Rap1 
normally (Fig. 10 C). Thus Rac2 appears to play a selective 
integrin ligand ICAM-1 was tethered to a planar lipid bilayer 
(Carrasco et al., 2004). We found that although WT and 
Rac1-deficient  B  cells  adhered  strongly  to  ICAM-1  in   
response to CXCL12 and CXCL13, Rac2/ B cells showed 
a large reduction in adhesion (Fig. 10 B). A similar reduced 
adhesion was also seen after treatment of Rac2/ B cells 
with Mn2+, which activates integrins directly. In contrast, 
treatment of B cells with phorbol ester and ionomycin re-
sulted in efficient adhesion, irrespective of genotype, demon-
strating that Rac2-deficient B cells are able to adhere to 
ICAM-1 if signaling pathways are bypassed pharmacologi-
cally. Collectively, these results show that Rac2 plays an 
important role in outside-in signaling from LFA-1 that leads 
to firm adhesion, and may also participate in transducing 
Figure 8.  Expression of Bcl-xL in transitional B cells deficient in Rac1 and Rac2 rescues survival and development but not migration. Irradi-
ated Rag1-deficient mice were reconstituted with bone marrow cells from WT or Rac1BRac2/ mice that had been infected with MIGR1–Bcl-xL, a retro-
viral vector expressing GFP and Bcl-xL, or with a control vector (MIGR1) expressing only GFP. (A) Histograms show fluorescence of staining with an 
anti–Bcl-xL or isotype control antibody of GFP+ or GFP splenic T2 B cells from chimeras reconstituted with WT or Rac1BRac2/ bone marrow cells in-
fected with MIGR1–Bcl-xL. No increase in Bcl-xL expression was seen in T2 cells from chimeras reconstituted with cells infected with the MIGR1 vector 
control (not depicted; n = 3). (B) Contour plots show IgD and CD23 expression on B220+CD93+IgMhiGFP+ splenocytes from chimeras reconstituted with 
WT or Rac1BRac2/ bone marrow cells infected with MIGR1 (Control) or MIGR1–Bcl-xL (Bcl-xL) vectors. Numbers indicate percentages of cells falling 
into quadrants. (C) Mean (±SEM) percentage of B220+CD93+IgMhiGFP+ transitional splenocytes from chimeras described in B that were T0 (IgDCD23), 
T1 IgD+ (IgD+CD23), and T2 (IgD+CD23+), gated as in B (n > 4). (D) Mean (±SEM) percent migration in a Transwell assay of B220+IgMhiGFP+ T0, T1 IgD+, 
and T2/MRF splenocytes from chimeras described in B. Migration was measured in response to no chemokine or the indicated chemokines. Colors of bars 
are as in C (n > 8). *, P < 0.05; **, P < 0.01. No Chmk, no chemokine.JEM VOL. 207, April 12, 2010 
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role in transducing BCR but not chemokine receptor signals 
leading to Rap1 activation. Finally, we examined chemokine-
induced actin polymerization, a process known to be regu-
Figure 9.  Vav family proteins are not required for entry into splenic white pulp. (A) Contour plots of splenocytes from either WT (B10.BR) or 
Vav1/Vav2/Vav3/ (VavTKO) mice showing separation of B220+ cells into immature (CD93+) and mature (CD93) B cells. Note that the VavTKO 
mice are on a B10.BR background and are therefore compared with WT B10.BR mice. The immature cells were further gated on IgM+ cells and separated 
according to the expression of IgD and CD23 into T0 (IgDCD23), T1 IgD+ (IgD+CD23), and T2 (IgD+CD23+) subsets. Mature (CD93) cells were sepa-
rated according to expression of IgM and CD23 into MRF (IgM+/CD23+) and MZ (IgM+CD23) subsets (not depicted). Numbers show percentages of 
cells falling into gates or quadrants. (B) Mean (±SEM) number of splenic T0, T1 IgD+, T2, and MRF B cells in WT (n = 5), Rac1BRac2/ (n = 7), B10.BR, 
and VavTKO mice (n = 7). (C) Mean (±SEM) migration in a Transwell assay of T0, T1 IgD+, and T2 splenic B cells from WT (B10.BR) or VavTKO mice in re-
sponse to the indicated chemokines (n = 6). (D) Images showing immunofluorescence staining of sections from spleens of mice into which WT (B10.BR) 
or VavTKO (IgMb) T0 B cells had been transferred 24 h earlier. Staining for IgMb (green) identifies transferred T0 B cells, and MadCAM-1 (red) defines the 
edges of the white pulp. Bar, 150 µm. The graph shows the mean (±SEM) ratio of transferred IgMb+ T0 B cells ending up in white relative to red splenic 
pulp 24 h after transfer (n = 4). *, P < 0.05; **, P < 0.01. No Chmk, no chemokine.
lated by chemokine receptor signaling. Absence of Rac2 
resulted in reduced basal and chemokine-induced actin po-
lymerization (Fig. 10 D). Collectively, these results show 848 Migration in transitional B cell development | Henderson et al.
Lindsley et al., 2007). Our BrdU incorporation data support 
this conclusion, as we find that the output from the splenic T1 
IgD+ compartment is insufficient to account for the observed 
cellular input into the T2 compartment, indicating that there 
must be input from other sources. Indeed, although most im-
mature B cells in the bone marrow are like T0, some express 
IgD and hence are more like T1 IgD+ or T2 cells. Thus, it   
appears that the transitional B cells migrating from the bone 
marrow to the spleen are likely to be a mixture of T0, T1 
IgD+, and T2 cells, as was seen in the blood (Fig. S1 A).
This subdivision into T0 and T1 IgD+ subsets appears to 
be of functional significance, as we show that T0 B cells are 
unable to enter the splenic white pulp until they mature into 
the T1 IgD+ or T2 subsets. The homing and retention of   
developing B cells into different lymphoid organs is under   
the control of chemokine receptors. Although early B cell   
progenitors  (pro–B  and  pre–B  cells)  require  CXCR4  for   
retention in the bone marrow, homing and retention of ma-
ture B cells in the spleen require CXCR5 and CCR7 (Ma et al., 
1999; Ohl et al., 2003; Nie et al., 2004). This suggests that 
that Rac2 participates in chemokine receptor signals leading 
to  actin  polymerization  but  not  in  those  required  for   
Rap1 activation.
DISCUSSION
Analysis of splenic B cell development in mice deficient in 
Rac1 and Rac2 has allowed us to identify a transitional subset 
that we term T0. Allman et al. (2001) previously described the 
T1 subset as the earliest B cell immigrants into the spleen. We 
have now subdivided these cells on the basis of IgD expression 
into T0 (IgD) cells and T1 IgD+ cells. Our studies support 
the hypothesis that T0 cells are direct precursors of T1 IgD+ 
and T2 cells. BrdU labeling experiments show that splenic T0 
cells acquire BrdU more slowly than immature B cells in the 
bone marrow but do so more rapidly than splenic T1 IgD+ 
and T2 cells. Furthermore, transferred T0 cells mature into T1 
IgD+ and T2 cells within 24 h. Recent studies have shown 
that immature B cells can mature into T2 cells already in the 
marrow, before migrating to the spleen and other peripheral 
lymphoid organs (Shahaf et al., 2004; Cariappa et al., 2007; 
Figure 10.  Rac1 and Rac2 are required for chemokine-induced integrin adhesion. (A) Images showing immunofluorescence staining of sections 
from spleens of mice into which WT, Rac1B, or Rac2/ CFSE-labeled MRF B cells had been transferred 4 h earlier. CFSE (green) identifies transferred  
B cells, and staining for MadCAM-1 (red) defines the edges of the white pulp. Bar, 300 µm. The graph shows the mean (±SEM) ratio of transferred MRF  
B cells ending up in white relative to red splenic pulp 4 h after transfer (n = 5). (B) Mean (±SEM) adhesion of splenic MRF B cells from mice of the indicated  
genotypes to either ICAM-1 or VCAM-1 incorporated into lipid bilayers. B cells were either unstimulated (Unst) or treated with phorbol 12,13-dibutyrate 
and ionomycin (P+I), CXCL12, CXCL13, or Mn2+. (C) Immunoblots showing levels of Rap1-GTP pulled down using a GST-RBD-RalGDS fusion protein, and 
of total Rap1 in cell lysates of splenic MRF B cells from mice of the indicated genotypes stimulated with CXCL13 for the indicated times. (D) Graph show-
ing mean (±SEM) F-actin content in MRF B cells either unstimulated () or stimulated with the indicated chemokines, normalized to the F-actin content 
of WT unstimulated cells (100%; n = 5). Statistical significance in B and D was determined using an unpaired t test. *, P < 0.05; **, P < 0.01.JEM VOL. 207, April 12, 2010 
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poorly. In support of this, expression of Bcl-xL in Rac1BRac2/ 
transitional B cells reversed the developmental block, resulting 
in increased numbers of T1 IgD+ cells. In contrast, earlier ex-
periments had shown that ectopic expression of Bcl-2 did not 
rescue the developmental block in Syk/ transitional B cells 
(Turner et al., 1997). Collectively, these studies suggest that   
although  Syk  is  required  for  the  maturation  of  transitional   
B cells, presumably because it transduces BCR signals that drive 
this differentiation process, the Rac GTPases regulate survival 
of post-T0 stages but not the maturational process itself.
The similarity of the Rac1BRac2/ phenotype to that 
seen after treatment with pertussis toxin and the inability of 
Rac-deficient transitional cells to respond to CCL21 and 
CXCL13 suggest that in both cases the impaired survival of 
T1 IgD+ and T2 cells may be caused by a failure to migrate 
to the splenic white pulp in response to chemokines. This 
migration may be required for transitional B cells to access 
niches providing survival factors. A key survival factor for 
transitional B cells is BAFF. Because BAFF is a soluble pro-
tein, it is presumably present in the red pulp. However, the 
observed failure of pertussis toxin–treated T1 IgD+ and T2 
cells to survive in the red pulp suggests that either BAFF must 
be presented to the cells within the white pulp, or that BAFF 
is not sufficient for survival and another survival signal is   
required that can only be delivered in the white pulp. Al-
though our results focus on early transitional B cell develop-
ment, further maturational steps within late transitional B 
cells have been well defined in terms of response to BAFF 
and selection into the MRF and MZ pools (Saito et al., 2003; 
Pillai et al., 2004; Srivastava et al., 2005; Meyer-Bahlburg   
et al., 2008). Here, once again, signals from the BCR and 
environmental cues are critically involved.
We note that in the absence of Rac GTPases we also see 
a  developmental  block  between  T0-  and  T1  IgD+–like   
immature B cells in the bone marrow. By analogy with our 
results in the spleen, this block may indicate that survival of 
T1 IgD+– and T2-like immature bone marrow B cells also 
requires  migration  into  an  appropriate  niche,  such  as  the   
sinusoidal niche shown to be the location of MRF B cells and 
some immature B cells in the bone marrow (Cariappa et al., 
2005; Pereira et al., 2009). We speculate that the develop-
mental block in the bone marrow of Rac-deficient mice may 
be caused by an essential role for Rac GTPases in transducing 
signals from cannabinoid receptor 2, a GPCR required for 
the retention of immature B cells in bone marrow sinusoids 
(Pereira et al., 2009). More generally, this suggests that GPCRs 
other than chemokine receptors may also be important in   
directing B cell migration and hence development.
In earlier work we showed that Rac-deficient immature 
bone marrow B cells respond poorly to BAFF in vitro and 
proposed that this may contribute to the developmental block 
in the mutant mice (Walmsley et al., 2003). The current study 
suggests that the loss of Rac1 and Rac2 has also affected an-
other key pathway required for survival of transitional B cells 
involving chemokine-induced migration into the white pulp. 
We note that the reduction in T1 cells in mice with a mutation 
changing responsiveness to chemokines may determine the 
localization of developing B cells. In keeping with this, re-
sponsiveness of B cell progenitors in the marrow to CXCL12, 
the ligand for CXCR4, decreases as the cells mature from 
pro–B through pre–B to immature B cells, reaching a low 
point in mature B cells (Glodek et al., 2003). In contrast,   
mature B cells acquire the ability to respond to the CCR7   
ligands CCL19 and CCL21 and to CXCL13, the ligand for 
CXCR5 (Bowman et al., 2000). Our analysis of the chemo-
kine responsiveness of transitional B cells has shown that   
although T0 B cells respond poorly to CXCL12, CXCL13, 
and CCL21, T1 IgD+ and T2 B cells show increasing re-
sponses as maturation proceeds. Collectively, these data sug-
gests that during early B cell development in the bone marrow, 
B lineage cells gradually lose responsiveness to CXCL12, 
reaching a low in the immature/T0 stage, thereby allowing 
them to exit the bone marrow. Upon arrival in the spleen, T0 
cells mature into the T1 IgD+ and T2 stages, acquire respon-
siveness to CCL21 and CXCL13, and are thus able to enter 
the splenic white pulp and eventually the follicles.
The maturation of B cells through the transitional stages 
corresponds to the point at which the processes of positive 
and  negative  B  cell  selection  are  occurring  (Hardy  and   
Hayakawa, 2001). Immature B cells that have successfully 
generated a functional BCR in the form of IgM are positively 
selected, allowing them to continue maturation; cells that fail   
to make such a BCR are destined to die. In contrast, im-
mature B cells that generate a BCR with high affinity for a   
self-antigen are eliminated by apoptosis, anergy, or receptor 
editing in a process termed negative selection. The outcome 
of these selection events is dependent on BCR signaling. 
Weak BCR signaling is thought to drive positive selection, 
whereas strong BCR signaling leads to negative selection. In 
this study, we have shown that in the absence of Syk, a criti-
cal  signal  transducing  molecule  downstream  of  the  BCR   
required for positive selection (Turner et al., 1997), B cell 
maturation is blocked at the splenic T0 stage, with cells   
located primarily in the red pulp. Thus, we propose that a 
critical outcome of the BCR signals driving positive selection 
is a change in the ability of immature and transitional B cells 
to respond to different chemokines. Such BCR signals would 
cause immature B cells to become less responsive to CXCL12 
and more responsive to CCL21 and CXCL13, thereby caus-
ing the cells to exit the marrow and home to the white pulp 
of the spleen. Furthermore, we propose that the maturation of 
T0 B cells into T1 IgD+ B cells, which can occur in either the 
bone marrow or spleen, represents the point at which B cell 
positive selection is acting to change cellular homing.
The  strong  developmental  block  between  T0  and  T1 
IgD+ B cells in Rac-deficient mice is most likely caused by a 
critical role for the GTPases in survival of T1 IgD+ and T2 
cells. We found no evidence that the absence of Rac GTPases 
causes maturational arrest, because there is no accumulation 
of T0 cells in Rac-deficient mice. In contrast, mutant T0 
cells were able to mature into T1 IgD+ and T2 cells after 
transfer into WT hosts, but these latter populations survived 850 Migration in transitional B cell development | Henderson et al.
the absence of Rac1 and Rac2, B cell development is arrested 
at the T0 stage potentially because the later transitional subsets 
are unable to respond to chemokines and, thus, to migrate into 
the white pulp and survive. The same developmental block at 
the T0 stage is seen in the absence of Syk, suggesting that the 
maturation of T0 cells into T1 and T2 cells and their subse-
quent migration into the white pulp may represent a key step 
in the positive selection of developing B cells.
MATERIALS AND METHODS
Mice
Mice bearing a conditional loxP-flanked allele of Rac1 (Rac1flox/flox; Walmsley 
et al., 2003) and Rac2-deficient mice (Rac2/; Roberts et al., 1999) were 
crossed with CD19Cre/+ mice in which the Cre recombinase had been 
knocked into the CD19 gene (Rickert et al., 1997) to generate mice defi-
cient  in  Rac1  (Rac1flox/floxCD19Cre/+;  Rac1B),  Rac2  (Rac2/CD19Cre/+; 
Rac2/),  or  both  (Rac1flox/floxRac2/CD19Cre/+;  Rac1BRac2/).   
CD19Cre/+ mice were used as control WT mice. Mice deficient in Vav1, 
Vav2,  and  Vav3  (Vav1/Vav2/Vav3/)  on  a  B10.BR  background 
(Vigorito et al., 2005) were compared with WT B10.BR mice. Mice   
heterozygous for a null mutation in Syk (Syk+/) were maintained on a B6 
background (Turner et al., 1995). Inbred strains used in this study included 
129S8, C57BL6/J, B6.SJL, B10.BR, and C3H/HeJ. Rac2/ mice were 
obtained  from  D.  Williams  (Children’s  Hospital,  Boston,  MA)  and   
CD19Cre/+ mice were obtained from J. Roes (University College London, 
London, England, UK). All mice were bred, maintained, and used under 
the control of a project license issued by the UK Home Office.
Flow cytometric analysis and cell sorting
Bone marrow cells were obtained by flushing out the femurs and tibias of 
both hind legs. Splenocytes were isolated by pushing the spleen through a 
70-µm sieve, and blood, taken by cardiac puncture, was collected into 50 µl 
of 0.5 M EDTA. Erythrocytes were lysed by incubating cell suspensions for 
2 min in 150 mM NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA, pH 7.2–7.4. 
Cells  were  incubated  with  Fc  receptor  blocking  antibody  2.4G2  (anti-
CD16/CD32) before staining at 4°C in PBS, 0.5% BSA, 0.01% NaN3  
containing the specific pretitered antibodies. Biotin- and fluorophore- 
conjugated antibodies against the following cell-surface proteins were used: 
IgM, IgMa, IgMb, IgD, CD2, CD23, B220, CD93, CD45.1, CD45.2, 
CXCR4, CXCR5, CD11a (L integrin), CD18 (2 integrin), CD29 (1 
integrin), and CD49d (4 integrin), as well as streptavidin conjugates   
(obtained from BD, eBioscience, SouthernBiotech, Jackson Immuno-
Research Laboratories, Inc., and Invitrogen). To measure intracellular levels 
of Bcl-xL, cells were stained with antibodies to cell-surface proteins as   
described, fixed in 3% paraformaldehyde at room temperature for 25 min, 
permeabilized in 0.1% NP-40 for 2 min, blocked with 1% BSA for 20 min, 
and stained with PE-conjugated anti–Bcl-xL (7B2.5; Abcam) or IgG3 as an 
isotype control. Five- or six-color analysis was performed on cytometers 
(LSR II and FACSCanto II; BD), and data were analyzed using FlowJo soft-
ware (Tree Star, Inc.). Cell numbers were calculated for a whole spleen or 
for the marrow from two femurs and two tibias.
To measure turnover of cell populations, mice were injected i.p. with 1 mg 
BrdU in PBS (Sigma-Aldrich). Thereafter, the mice were given 1 mg/ml 
BrdU in their drinking water either continuously or, for a pulse-chase study, 
for a period of only 16 h before being returned to normal drinking water. 
Splenocytes were harvested at different times and stained with antibodies to 
cell-surface proteins, and BrdU incorporation into DNA was measured using 
a BrdU with DNase kit (BD) according to the manufacturer’s instructions.
In vivo maturation, migration, and survival
To isolate T0 B cells for transfer assays, splenocytes from 2-wk-old mice 
were depleted using biotinylated anti-IgD and anti-CD23 antibodies and 
streptavidin M-280 Dynabeads (Invitrogen). In the resulting cell prepara-
tion, typically >70% were T0 (IgDCD23) B cells and >95% were CD23 
in the BAFF receptor BAFF-R is less severe than that in   
Rac1BRac2/ mice (Lentz et al., 1998; Thompson et al., 2001; 
Yan et al., 2001; Amanna et al., 2003), and hence we propose 
that the developmental block seen in the absence of Rac1 and 
Rac2 is likely to be caused by the combination of defects in both 
BAFF responsiveness and migration into the white pulp.
The precise biochemical role for Rac GTPases in re-
sponses to chemokines remains unclear. An important event 
downstream of chemokine signaling is the activation of inte-
grins by inside-out signaling, binding of integrins to their   
ligands, outside-in signaling from the integrin, and subse-
quent  adhesion.  We  have  shown  that  chemokine-induced   
adhesion through the integrin LFA-1 is dependent on Rac2 in 
mature B cells. The defective adhesion to ICAM-1 in Rac2/ 
B cells treated with Mn2+ suggests that Rac2 is required to 
transduce outside-in signals from LFA-1. These might poten-
tially involve regulation of the actin cytoskeleton, because this 
is a critical event in cell adhesion, and we and others have 
shown that Rac2-deficient B cells have decreased levels of 
polymerized actin (Croker et al., 2002). From the results   
presented in this study it is not possible to deduce if Rac   
GTPases also play a role in inside-out activation of integrins. 
That they may do so is suggested by our recently reported 
study showing that Rac2 deficiency resulted in a small decrease 
in BCR-induced activation of the Rap1 GTPase, which is a 
key transducer of inside-out signals leading to integrin activa-
tion (Arana et al., 2008). However, we now find that chemo-
kine-induced Rap1 activation is unaffected by the absence of 
Rac2, suggesting that Rac2 participates differentially in BCR 
and chemokine receptor signaling pathways.
Earlier reports have suggested that in T cells, Vav proteins 
may have important roles in transducing CXCR4 signals to 
the activation of integrins and that they may also transduce 
outside-in signals from both 1 and 2 integrins, presumably 
via  Rac  GTPases  (del  Pozo  et  al.,  2003;  Sánchez-Martín   
et al., 2004; García-Bernal et al., 2005; Vicente-Manzanares 
et  al.,  2005).  However,  our  studies  using  VavTKO  mice 
show that a deficiency of all three Vav proteins causes a B cell 
developmental block, which is distinct from that seen in the 
absence of Rac1 and Rac2, has no effect on the ability of 
transitional B cells to enter the splenic white pulp, and only 
partially affects chemokine-induced migration. These results 
demonstrate that the Vav proteins do not play an important 
role downstream of chemokine or integrin receptors, at least 
in transitional B cells. Instead, a more likely candidate for a 
GEF that transduces chemokine receptor signals to the activa-
tion of Rac GTPases is DOCK2, because DOCK2-deficient 
B cells show greatly reduced CXCR4- and CXCR5-induced 
migration, and decreased Rac1 and integrin activation (Fukui 
et al., 2001; Nombela-Arrieta et al., 2004).
In conclusion, we have identified an IgD transitional 
subset of B cells that we term T0, which corresponds to the 
most recently arrived developing B cells in the spleen. We 
have shown that these cells are unable to enter the splenic 
white pulp until they mature into T1 IgD+ and T2 B cells and 
that this migration is essential for survival. Furthermore, in JEM VOL. 207, April 12, 2010 
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(106 cells/well). Cells were allowed to migrate for 3 h at 37°C through the 
Transwell insert. Cells that had migrated into the lower chamber were col-
lected, a set number of PerCP CaliBRITE beads (BD) were added to allow 
quantification of cell number, and cells were stained with antibodies to B220, 
CD93, CD23, IgM, and IgD. Flow cytometric analysis established percentages 
of cells falling into T0, T1 IgD+, and T2 subsets, and recovery of CaliBRITE 
beads was used to calculate absolute numbers of cells that had transmigrated, 
which was then expressed as the percent migration compared with the number 
of cells in each of these subsets in the input population of cells. Data shown in 
the figures are representative of three independent experiments.
Ectopic expression of Bcl-xL in radiation chimeras
Plat-E packaging cells (Morita et al., 2000) were transfected with either the 
control GFP-expressing MIGR1 retroviral vector (Pear et al., 1998) or the 
MIGR1–Bcl-xL vector using Genejuice (EMD) according to the manufac-
turer’s protocol. MIGR1–Bcl-xL consists of MIGR1 with a human Bcl-xL 
cDNA inserted into the EcoRI site such that it expresses both Bcl-xL and 
GFP (provided by D. Allman and W. Pear, University of Pennsylvania, 
Philadelphia, PA). Supernatant containing retrovirus was harvested from the 
cells 48–72 h after transfection, passed through a 0.45-µm filter, and concen-
trated by centrifugation at 15,000 g for 2 h at 4°C.
Bone marrow cells were harvested from WT or Rac1BRac2/ mice 
treated 5 d earlier with 100 mg/kg 5-fluorouracil i.p. (Autogen Bioclear) and 
cultured overnight in DMEM, 10% FBS, 100 U/ml penicillin, 0.1 mg/ml   
streptomycin, 1× nonessential amino acids (Invitrogen), 2 mM glutamine,   
50 µM 2-mercaptoethanol, 6 ng/ml IL-3, 10 ng/ml IL-6, and 100 ng/ml 
stem cell factor (all growth factors were obtained from PeproTech), and were 
then infected by culturing in plates coated with 25 µg/ml of recombinant 
human fibronectin fragment (Retronectin; Lonza) in the presence of con-
centrated retroviral supernatant for 24 h, and were infected a second time 
with fresh retroviral supernatant for a further 24 h. Infected bone marrow 
cells were injected i.v. into B6-Rag1tm1Mom/tm1Mom mice that had received two 
doses of 5 Gy of total body irradiation from a 137Cs source administered 3 h 
apart. Bone marrow cells from one donor mouse were transferred into two 
recipient mice. Mice were treated with Baytril (Bayer HealthCare) in their 
drinking water and analyzed 4–5 wk after reconstitution.
Radiation chimeras with Syk-deficient hematopoietic cells
To examine B cell development in the absence of Syk, E15.5 fetal liver cells 
from Syk/ or Syk+/+ embryos generated by intercrossing of Syk+/ mice   
were used to reconstitute the hematopoietic system of either B6.SJL- 
Rag2/ (Ly5.1+) mice given 4.5 Gy of irradiation from a 137Cs source or 129S8 
mice given two doses of 4.5 Gy of irradiation 3 h apart to minimize gastro-
intestinal tract damage. The B6.SJL-Rag2/ chimeras were used to calculate 
numbers of cells in B cell subsets; the 129S8 chimeras were used to generate 
splenic sections. Mice were treated with Baytril in their drinking water for at 
least 4 wk after transfer and were analyzed 6–8 wk after the transfer.
Adhesion assay
Planar  lipid  bilayers  containing  glycophosphatidylinositol-linked  Alexa 
Fluor  532–conjugated  ICAM-1  (100  molecules/µm2)  were  prepared  in 
FCS2 chambers (Bioptechs) as described previously (Carrasco et al., 2004). 
Bilayers were preincubated with 250 ng/ml CXCL12 or CXCL13, and 107 
MRF B cells were incubated with bilayers for 20 min at 37°C in PBS, 0.5% 
FCS, 2 mM MgCl2, 0.5 mM CaCl2, 5.5 mM glucose. Alternatively, B cells 
were pretreated with 10 ng/ml phorbol 12,13-dibutyrate, 1 µg/ml ionomy-
cin for 20 min at 37°C before placing on bilayers. To switch integrins into 
their active conformation, B cells were incubated with bilayers for 20 min at 
37°C in 10 mM MnCl2, 20 mM Hepes, 140 mM NaCl, 2 mg/ml glucose. 
Several images were taken of independent areas on bilayers with interfer-
ence reflection microscopy (IRM) and analyzed as described previously to 
establish the percentage of adherent cells (Arana et al., 2008). B cells with a 
minimum 2 µm2 of IRM dark area were defined as being adherent. Data 
shown in the figures are representative of three independent experiments. 
Statistical analysis was performed using an unpaired t test.
B cells. To isolate MRF B cells, splenocytes from 6–8-wk-old mice were 
depleted using biotinylated antibodies to CD43, Gr1, and Mac1, resulting in 
a preparation containing >90% B cells.
Maturation and survival assay. Transitional B cells from the CD19Cre/+ 
strains (IgMb+) were injected i.v. into 129S8 (IgMa+) recipients (1–3 × 107 
cells/mouse). Input samples, as well as splenocytes recovered 4 and 24 h   
after transfer were stained with antibodies to IgD, IgMa, IgMb, CD23, 
CD93, and B220.
Competitive migration assays. Transitional B cells from the CD19Cre/+ 
strains (IgMb+Ly5.2+) were mixed with an equal number of transitional B 
cells from 129S8 mice (IgMa+Ly5.2+) and were injected i.v. into B6.SJL 
(IgMb+Ly5.1+) recipients (1–3 × 107 cells of each population/mouse). The 
input cell mixture and cells recovered from the blood, spleen, and bone   
marrow 4 h after transfer were analyzed by staining with antibodies to IgMa, 
IgMb, Ly5.1, and Ly5.2. Efficiencies of migration and survival were calcu-
lated by normalizing the IgMb/IgMa ratio of recovered Ly5.2+ cells to the 
IgMb/IgMa ratio of injected cells.
Migration into splenic white pulp. Transitional or MRF B cells from the 
CD19Cre/+ strains (IgMb+) were injected i.v. into 129S8 (IgMa+) recipients. 
Transitional B cells from the Vav1/Vav2/Vav3/ or B10.BR strains 
(IgMb+) were injected i.v. into C3H/HeJ (IgMa+) recipients. In all cases,   
1–3 × 107 cells were injected per mouse. MRF B cells were labeled with   
2 µM CFSE (Invitrogen) in Dulbecco’s-PBS (Invitrogen) for 10 min at 37°C 
and washed before injection. Spleens were harvested 4 and 24 h after transfer 
and snap frozen in liquid nitrogen.
To inhibit CXCR4 function, recipient mice were injected s.c. with   
5 mg/kg AMD3100 (Sigma-Aldrich) 30 min before transfer of cells. To block 
LFA-1 and VLA-4, mice were injected i.p. with blocking antibodies anti-
CD11a (H68) and anti-CD49d (PS/2; 100 µg/mouse; a gift from N. Hogg, 
Cancer Research UK London Research Institute, London, England, UK) 
20 min before transfer of cells. In some experiments, transitional B cells were 
pretreated with pertussis toxin or an oligomer of the B subunit of pertussis 
toxin (both at 100 ng/ml; Sigma-Aldrich) for 2 h at 37°C before injection.
Immunohistochemistry
5–10-µm cryostat sections from snap-frozen spleens were dried for 1 h at 
room temperature, fixed in 90% acetone for 20 min, air dried for 10 min,   
incubated for 5 min in Tris, pH 7.6, and stained with mouse anti-IgMb–FITC 
(AF6-78) and rat anti–MadCAM-1 (MECA-367; AbD Serotec) for 1–1.5 h. 
Where MRF B cells had been transferred, the sections were also stained with 
mouse anti-IgDb–FITC (217-170). After washing, slides were incubated in a 
moist chamber with the secondary reagents anti-FITC labeled with Alexa 
Fluor 488 and anti–rat IgG labeled with Alexa Fluor 647 (Invitrogen), which 
had  been  preabsorbed  to  10%  normal  mouse  serum  and  centrifuged  to   
remove aggregates. Slides were washed in 0.5 M Tris, pH 7.6, washed in   
water, and mounted in fluorescent mounting medium (Dako). Images of five 
distinct regions were captured per spleen using an HCPL APO dry objective   
(20×, NA 0.7) on a confocal microscope (TSC SP2 AOBS; Leica). Red and 
white pulp areas, delineated by MadCAM-1 expression, were identified using 
Image J software (available at http://rsbweb.nih.gov/ij/), the number of B cells 
in each area was counted, and cell density was established by dividing the cell 
number by area. Finally, the ratio of cell density in white to red pulp areas was 
calculated. All cell counts were performed by an operator blind to genotype.
In vitro migration
Transwell plates (5-µm pore size; Costar) were either uncoated or precoated 
with 0.5 µg/ml of recombinant mICAM-1Fc, 3 µg/ml mMadCAM-1Fc, or 
3 µg/ml mVCAM-1Fc (R&D Systems), washed three times with PBS, and 
preincubated with chemotaxis buffer RPMI 1640, 2 mM glutamine, 0.5% 
BSA at 37°C for 1 h. 1 µg/ml CCL21, 0.2 µg/ml CXCL12, or 1 µg/ml 
CXCL13 (R&D Systems) were added to the lower chamber, whereas spleno-
cytes prepared from 4-wk-old mice were added to the upper chamber   852 Migration in transitional B cell development | Henderson et al.
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Rap1 activation assay
Purified splenic MRF B cells were resuspended in HBSS (1–2 × 107 cells   
per stimulation) and stimulated with 0.5 µg/ml CXCL13 at 37°C. Reactions 
were stopped by addition of an equal volume of cold 2× Rap lysis buffer   
(50 mM Tris HCl, pH 7.5, 300 mM NaCl, 10 mM MgCl2, 2% IGEPAL, 2 mM 
dithiothreitol, 10% glycerol, 1:50 vol/vol protease inhibitor cocktail [P8340; 
Sigma-Aldrich]). Active Rap1-GTP was pulled down and analyzed by SDS-
PAGE and immunoblotting according to the EZ-Detect Rap1 activation kit 
protocol (Thermo Fisher Scientific). Signal on the immunoblots was re-
vealed using anti–rabbit Ig–horseradish peroxidase, and blots were washed six 
times for 10 min in PBS, 0.05% Tween 20 and developed using the West Femto 
Maximum Sensitivity Substrate (SuperSignal; Thermo Fisher Scientific). Data 
shown in the figures are representative of three independent experiments.
F-Actin measurement
2 × 106 purified splenic MRF B cells were resuspended in 0.5 ml HBSS and 
stimulated with 0.5 µg/ml CXCL12 or 200 ng/ml CXCL13 at 37°C for 15 s. 
Reactions were stopped by addition of paraformaldehyde to 3.7%, washed 
with 50 mM NH4Cl, permeabilized in 0.1% NP-40 for 2 min, blocked 
with 1% BSA for 20 min, stained for 30 min with 0.25 U Alexa Fluor 647–
conjugated phalloidin (Invitrogen), washed, and analyzed by flow cytom-
etry. Within each experiment, the mean of triplicate F-actin content 
measurements was normalized to that in unstimulated WT cells, which was 
set to 100%. Data from five independent experiments were combined and 
statistical analysis was performed using an unpaired t test.
Statistical analysis
All statistical comparisons were performed using the nonparametric two-tailed 
Mann-Whitney U test unless otherwise stated. Unless otherwise indicated, 
asterisks in figures indicate significant differences compared with WT cells.
Online supplemental material
Fig.  S1  shows  the  separation  of  immature  B  cells  according  to  expres-
sion  of  IgD  and  CD23  in  the  blood  and  bone  marrow  of  WT  and   
Rac1BRac2/ mice. Online supplemental material is available at http:// 
www.jem.org/cgi/content/full/jem.20091489/DC1.
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